Skip to main content

Table 2 Positive history patients’ data

From: Threshold for basophil activation test positivity in neuromuscular blocking agents hypersensitivity reactions

Number

Sex

Substance

Clinical symptoms

SPT

IDT

SI

Ba%

1

M

Rocuronium

Shock

Positive

 

6.06

10.73

2

M

Suxamethonium

Shock

Positive

 

2.10

31.56

3

M

Pancuronium

Shock

Negative

Positive

1.06

7.15

4

M

Rocuronium

Urticaria

Positive

 

2.60

13.00

5

F

Pancuronium

Bronchospasm

Negative

Positive

3.23

17.11

6

F

Rocuronium

Shock

Positive

 

2.05

14.48

7

F

Atracurium

Shock

Positive

 

0.93

2.17

8

F

Rocuronium

Shock

Negative

Positive

5.22

25.15

9

F

Atracurium

Shock

Positive

 

7.68

20.50

10

F

Atracurium

Angioedema

Negative

Positive

1.86

3.54

11

F

Atracurium

Angioedema

Positive

 

1.99

13.29

12

F

Atracurium

Shock

Positive

 

4.81

7.93

13

F

Atracurium

Urticaria

Positive

 

3.89

8.91

14

F

Atracurium

Hypotension

Negative

Positive

2.01

6.48

15

F

Rocuronium

Hypotension

Positive

 

0.52

2.14

16

M

Rocuronium

Urticaria

Positive

 

4.62

18.68

17

M

Atracurium

Bronchospasm

Negative

Positive

9.11

20.67

18

F

Rocuronium

Bronchospasm

Positive

 

1.60

7.19

19

F

Atracurium

Shock

Negative

Positive

5.03

5.08

20

F

Atracurium

Shock

Negative

Positive

2.62

3.54

21

F

Rocuronium

Urticaria

Negative

Positive

4.82

10.26

22

F

Atracurium

Shock

Negative

Positive

1.48

2.67

  1. M = Masculine; F = Feminine; Ba% = The highest percentage of activated basophils from c1, c2 and c3 concentrations for each NMBA; SPT = Skin prick test; IDT = Intradermal test; SI = The highest stimulation index from c1, c2 and c3 concentrations for each NMBA.